Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Quotient Therapeutics has raised $50.0M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
Quotient Therapeutics's investors include Flagship Pioneering.
Quotient Therapeutics is headquartered in London, United Kingdom.
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Quotient Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quotient Therapeutics — Funding & Investors." VCBacked, November 21, 2023, https://www.vcbacked.co/company/quotient-therapeutics. Accessed October 29, 2026.
VCBacked. (2023). Quotient Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/quotient-therapeutics
{{cite web |title=Quotient Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quotient-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated